Table 2.
All patients N=2,310 (n, %) |
GG 1 N=906 (n, %) |
GG 2 N=1,048 (n, %) |
GG 3 N=231 (n, %) |
GG 4 N=69 (n, %) |
GG 5 N=56 (n, %) |
|
---|---|---|---|---|---|---|
| ||||||
RP GG | ||||||
1 | 514 (22.2) | 434 (48) | 78 (7) | 1 (0.5) | 0 (0) | 0 (0) |
2 | 1,287 (56) | 430 (47) | 771 (74) | 73 (32) | 10 (14) | 3 (0.5) |
3 | 349 (15) | 29 (3) | 170 (16) | 116 (50) | 21 (30) | 13 (23) |
4 | 54 (2.2) | 9 (1) | 12 (1) | 17 (7) | 15 (22) | 1 (1.8) |
5 | 106 (4.6) | 4 (1) | 17 (2) | 23 (10.5) | 23 (34) | 39 (74.7) |
| ||||||
pT | ||||||
pT2 | 1,766 (76.5) | 827 (91.3) | 763 (72.8) | 130 (56.3) | 33 (47.8) | 13 (23.2) |
pT3a | 370 (16.0) | 68 (7.5) | 200 (19.1) | 63 (27.3) | 20 (29.0) | 19 (33.9) |
pT3b | 174 (7.5) | 11 (1.2) | 85 (8.1) | 38 (16.5) | 16 (23.2) | 24 (42.9) |
| ||||||
pN | ||||||
pN0 | 1,838 (79.6) | 619 (68.3) | 896 (85.5) | 209 (90.5) | 67 (97.1) | 47 (83.9) |
pN1 | 34 (1.5) | 2 (0.2) | 14 (1.3) | 10 (4.3) | 1 (1.5) | 7 (12.5) |
pNx | 438 (19.0) | 285 (31.5) | 138 (13.2) | 12 (5.2) | 1 (1.5) | 2 (3.6) |
| ||||||
Surgical margins | ||||||
pT2 | ||||||
Negative | 1,324 (75.0) | 636 (76.9) | 559 (73.3) | 94 (72.3) | 26 (78.8) | 9 (69.2) |
Positive | 442 (25.0) | 191 (23.1) | 204 (26.7) | 36 (27.7) | 7 (21.2) | 4 (30.8) |
≥ pT3 | ||||||
Negative | 271 (49.8) | 33 (41.8) | 153 (53.7) | 47 (46.5) | 18 (50.0) | 20 (46.5) |
Positive | 273 (50.2) | 46 (58.2) | 132 (46.2) | 54 (53.5) | 18 (50.0) | 23 (53.5) |
| ||||||
EPE | ||||||
Absent | 1,745 (75.5) | 719 (79.4) | 778 (74.2) | 158 (68.4) | 51 (73.9) | 39 (69.6) |
Focal | 263 (11.4) | 97 (10.7) | 125 (11.9) | 30 (13.0) | 7 (10.1) | 4 (7.1) |
Established | 302 (13.1) | 90 (9.9) | 145 (13.8) | 43 (18.6) | 11 (15.9) | 13 (23.2) |
| ||||||
SVI | ||||||
Absent | 2,137 (92.5) | 895 (98.8) | 963 (91.9) | 193 (83.6) | 53 (76.8) | 33 (58.9) |
Present | 173 (7.5) | 11 (1.2) | 85 (8.1) | 38 (16.5) | 16 (23.2) | 23 (41.1) |
Abbreviations: EPE, extraprostatic extension; GG, Grade Group; RP, radical prostatectomy; SVI, seminal vesicle invasion.